MDMA's new executive director Stephen Northrup focusing on reimbursement issues, FDAMA implementation.
This article was originally published in The Gray Sheet
Executive Summary
MDMA's NEW EXECUTIVE DIRECTOR STEPHEN NORTHRUP will be tasked with addressing coverage and reimbursement issues over the coming months, the Medical Device Manufacturers Association states in a Jan. 27 announcement. Effective Feb. 2, Northrup replaces outgoing Executive Director Jeffrey Kimbell, who is leaving to start his own Washington, D.C.-based lobbying firm, Jeffrey J. Kimbell & Associates.